Advanced Diabetes Centre Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 2.31 Cr
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.01 Cr
- Revenue Growth -16.63%
- Profit Growth 68.35%
- Ebitda 152.76%
- Net Worth -28.26%
- Total Assets -7.78%
About Advanced Diabetes Centre
Advanced Diabetes Centre Private Limited (ADCPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 September 2014 and has a history of Ten years and five months. Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.31 Cr.
The company currently has active open charges totaling ₹1.01 Cr.
Company Details
-
Location
Surat, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85110GJ2014PTC080673
-
Company No.
080673
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Sep 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Advanced Diabetes Centre?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Hetul Mehta | Director | 02-Sep-2014 | Current |
Amish Shah | Director | 02-Sep-2014 | Current |
Financial Performance of Advanced Diabetes Centre.
Advanced Diabetes Centre Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.63% decrease. The company also saw a substantial improvement in profitability, with a 68.35% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Advanced Diabetes Centre?
Unlock access to Advanced Diabetes Centre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.01 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.01 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
19 Apr 2018 | Hdfc Bank Limited | ₹1.01 Cr | Open |
How Many Employees Work at Advanced Diabetes Centre?
Unlock and access historical data on people associated with Advanced Diabetes Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanced Diabetes Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Diabetes Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.